泰国药剂师的制药公共卫生能力:一个范围审查与专家咨询
Thanayut Auimekhakul1,2, Siritree Suttajit3, Puckwipa Suwannaprom3
1Consumer Health Protection and Pharmaceutical Public Health, Chiang Mai Provincial Public Health Office, Chiang Mai 50200, Thailand.
概括
为公共卫生服务中的泰国药剂师制定了一个新的能力框架. 它概述了5个领域,包括健康促进,社区赋权和药物流行病学,这些领域对于劳动力发展至关重要.
科学领域:
- 制药科学 制药科学
- 公共卫生 公共卫生
- 医疗卫生工作人员发展发展
背景情况:
- 泰国药剂师的角色正在向以系统为中心的公共卫生服务发展.
- 一个明确的能力框架对于发展这支劳动力至关重要.
- 这项研究解决了在公共卫生领域为泰国药剂师提供专业能力框架的需求.
研究的目的:
- 系统地审查和综合有关制药公共卫生能力的现有文献.
- 为泰国公共卫生药剂师制定一个全面的能力框架.
- 通过专家共识验证拟议的框架.
主要方法:
- 在Scopus,MEDLINE和Web of Science数据库中进行广泛的文献搜索.
- 用于框架开发的诱导编码技术,然后使用修改后的Delphi方法进行验证.
- 包括2011-2020年间发表的英语和泰国文档,以及未发表的材料.
主要成果:
- 确定了制药公共卫生领域的5个关键能力领域:个人/家庭健康促进,社区赋权,信息管理,健康传播和药物流行病学.
- 在每个领域内开发了详细的能力元素和行为陈述.
- 在专家审查后获得了高的有效性得分 (S-CVI为0.93),完善了框架.
结论:
- 为泰国药剂师建立了一个经过验证的药物公共卫生能力框架.
- 该框架为公共卫生药房的培训和发展提供了一个结构化的指南.
- 这有助于提高泰国药剂师在公共卫生服务提供方面的能力.
相关概念视频
Pharmacovigilance
826
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
826
Biopharmaceutics and Pharmacokinetics: Overview
2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K
Drug Control Governance: Regulatory Bodies and Their Impact
157
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
157
Analysis of Population Pharmacokinetic Data
252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252
International Nursing Organizations II
1.0K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.0K
Drug Administration and Therapy Phases: Overview
451
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
451


